Kenvue, the maker of Tylenol, is urging U.S. health regulators not to add an autism warning label to it and other ...
“For over a decade — and as recently as August — FDA has fully evaluated the emerging scientific evidence and repeatedly ...
Kenvue, the maker of Tylenol, opposes proposed changes to the product's safety label regarding potential links to autism and ...
Barchart on MSN
Tylenol-Maker Kenvue’s Stock Is Down 30% in 2025. Its Fate May Be in the FDA’s Hands.
Kenvue (KVUE) could really use some good news. The Johnson & Johnson (JNJ) spinoff faced longlasting troubles regarding its ...
A petition asks the FDA to change the label to better reflect research about a possible connection between acetaminophen use ...
A powerful new drug combo has yielded a major breakthrough for men battling an aggressive form of prostate cancer, ...
ScienceAlert on MSN
The World's Most Popular Pain Relief Drug May Induce Risky Behavior
The most commonly taken analgesic worldwide – and one of the most consumed drugs in the US – could be doing a lot more than ...
In today’s Pharmaceutical Executive Daily, we cover major leadership changes at Novo Nordisk, Kenvue’s request for the FDA to ...
The FDA defied the advice of its own drug safety experts to warn pregnant women about Tylenol for nearly a decade, internal documents reveal.
On Saturday, Oct. 25, 2025, from 10 a.m. to 2 p.m., the Lincoln Parish Sheriff’s Office will partner with the Drug Enforcement Administration to host ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback